Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Khaled M Musallam

Showing results (11-20 of 203) with videos related to

Pageof 21
Sort By:
Hemoglobin|September 14, 2011
Iron chelation therapy for transfusional iron overload: a swift evolutionKhaled M Musallam, Ali T Taher
Journal of the National Cancer Institute|October 28, 2009
Re: Anti-angiogenic therapy using thalidomide combined with chemotherapy in small cell lung cancer: a randomized, double-blind, placebo-controlled trialKhaled M Musallam, Ali T Taher
Blood|April 12, 2012
A new chelator in the houseAli T Taher, Khaled M Musallam
Current Medical Research and Opinion|October 21, 2017
Iron deficiency beyond erythropoiesis: should we be concerned?Khaled M Musallam, Ali T Taher
Journal of the American Society of Nephrology : JASN|June 9, 2012
Mechanisms of renal disease in β-thalassemiaKhaled M Musallam, Ali T Taher
Hemoglobin|December 17, 2009
Sickle cell disease at the dawn of the molecular eraMiguel R Abboud, Khaled M Musallam
Pediatric Blood & Cancer|December 16, 2010
Iron in sickle-cell disease: what have we learned over the years?Adlette Inati, Evelyne Khoriaty, Khaled M Musallam
CA: a Cancer Journal for Clinicians|April 16, 2024
Not only a Western world issue: Cancer incidence in younger individuals in the United Arab EmiratesHumaid O Al-Shamsi, Khaled M Musallam
Mediterranean Journal of Hematology and Infectious Diseases|June 30, 2011
Thalassemia and venous thromboembolismJulien Succar, Khaled M Musallam, Ali T Taher
Bone|November 2, 2010
Bone disease and skeletal complications in patients with β thalassemia majorRachid Haidar, Khaled M Musallam, Ali T Taher
Pageof 21

Showing results (11-20 of 203) with videos related to

Sort By:
Pageof 21
Hemoglobin|September 14, 2011
Iron chelation therapy for transfusional iron overload: a swift evolutionKhaled M Musallam, Ali T Taher
Journal of the National Cancer Institute|October 28, 2009
Re: Anti-angiogenic therapy using thalidomide combined with chemotherapy in small cell lung cancer: a randomized, double-blind, placebo-controlled trialKhaled M Musallam, Ali T Taher
Blood|April 12, 2012
A new chelator in the houseAli T Taher, Khaled M Musallam
Current Medical Research and Opinion|October 21, 2017
Iron deficiency beyond erythropoiesis: should we be concerned?Khaled M Musallam, Ali T Taher
Journal of the American Society of Nephrology : JASN|June 9, 2012
Mechanisms of renal disease in β-thalassemiaKhaled M Musallam, Ali T Taher
Hemoglobin|December 17, 2009
Sickle cell disease at the dawn of the molecular eraMiguel R Abboud, Khaled M Musallam
Pediatric Blood & Cancer|December 16, 2010
Iron in sickle-cell disease: what have we learned over the years?Adlette Inati, Evelyne Khoriaty, Khaled M Musallam
CA: a Cancer Journal for Clinicians|April 16, 2024
Not only a Western world issue: Cancer incidence in younger individuals in the United Arab EmiratesHumaid O Al-Shamsi, Khaled M Musallam
Mediterranean Journal of Hematology and Infectious Diseases|June 30, 2011
Thalassemia and venous thromboembolismJulien Succar, Khaled M Musallam, Ali T Taher
Bone|November 2, 2010
Bone disease and skeletal complications in patients with β thalassemia majorRachid Haidar, Khaled M Musallam, Ali T Taher
Pageof 21